• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与中心血液透析相比,新型家庭透析技术的成本是否仍然具有优势?一项意大利单中心分析及与西方国家经验的比较。

Is the cost of the new home dialysis techniques still advantageous compared to in-center hemodialysis? An Italian single center analysis and comparison with experiences from western countries.

作者信息

Iadarola Gian Maria, Giorda Elisa, Borca Marco, Morero Daniela, Sciascia Savino, Roccatello Dario

机构信息

University Center of Excellence on Nephrological, Rheumatological and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) Including Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), San Giovanni Bosco Hub Hospital, ASL Città di Torino and Department of Clinical and Biological Sciences of the University of Turin, Turin, Italy.

出版信息

Front Med (Lausanne). 2024 Mar 11;11:1345506. doi: 10.3389/fmed.2024.1345506. eCollection 2024.

DOI:10.3389/fmed.2024.1345506
PMID:38529121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10961330/
Abstract

INTRODUCTION

Potential advantages of home dialysis remained a questionable issue. Three main factors have to be considered: the progressive reduction in the cost of consumables for in-Center hemodialysis (IC-HD), the widespread use of incremental Peritoneal Dialysis (PD), and the renewed interest in home hemodialysis (H-HD) in the pandemic era. Registries data on prevalence of dialysis modalities generally report widespread underemployment of home dialysis despite PD and H-HD could potentially provide clinical benefits, improve quality of life, and contrast the diffusion of new infection among immunocompromised patients.

METHODS

We examined the economic impact of home dialysis by comparing the direct and indirect costs of PD (53 patients), H-HD (21 patients) and IC-HD (180 patients) in a single hospital of North-west Italy. In order to achieve comparable weekly costs, the average weekly frequency of dialysis sessions based on the dialysis modality was calculated, the cost of individual sessions per patient per week normalized, and the monthly and yearly costs were derived.

RESULTS

As expected, PD resulted the least expensive procedure (€ 23,314.79 per patient per year), but, notably, H-HD has a lower average cost than IC-HD (€ 35,535.00 vs. € 40,798.98). A cost analysis of the different dialysis procedures confirms the lower cost of PD, especially continuous ambulatory PD, compared to any extracorporeal technique.

DISCUSSION

Among the hemodialysis techniques, home bicarbonate HD showed the lowest costs, while the weekly cost of Frequent Home Hemodialysis was found to be comparable to In-Center Bicarbonate Hemodialysis.

摘要

引言

家庭透析的潜在优势仍是一个有争议的问题。需要考虑三个主要因素:中心血液透析(IC-HD)耗材成本的逐步降低、间歇性腹膜透析(PD)的广泛使用以及大流行时代对家庭血液透析(H-HD)重新产生的兴趣。尽管腹膜透析和家庭血液透析可能会带来临床益处、改善生活质量并减少免疫功能低下患者中新感染的传播,但透析方式患病率的登记数据通常显示家庭透析的利用率普遍较低。

方法

我们通过比较意大利西北部一家医院中腹膜透析(53例患者)、家庭血液透析(21例患者)和中心血液透析(180例患者)的直接和间接成本,研究了家庭透析的经济影响。为了实现可比的每周成本,根据透析方式计算了透析疗程的平均每周频率,对每位患者每周每次疗程的成本进行了标准化,并得出了每月和每年的成本。

结果

正如预期的那样,腹膜透析是成本最低的治疗方法(每位患者每年23,314.79欧元),但值得注意的是,家庭血液透析的平均成本低于中心血液透析(35,535.00欧元对40,798.98欧元)。对不同透析程序的成本分析证实,与任何体外技术相比,腹膜透析成本更低,尤其是持续非卧床腹膜透析。

讨论

在血液透析技术中,家庭碳酸氢盐血液透析成本最低,而频繁家庭血液透析的每周成本与中心碳酸氢盐血液透析相当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e6b/10961330/4e51b6836124/fmed-11-1345506-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e6b/10961330/4e51b6836124/fmed-11-1345506-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e6b/10961330/4e51b6836124/fmed-11-1345506-g001.jpg

相似文献

1
Is the cost of the new home dialysis techniques still advantageous compared to in-center hemodialysis? An Italian single center analysis and comparison with experiences from western countries.与中心血液透析相比,新型家庭透析技术的成本是否仍然具有优势?一项意大利单中心分析及与西方国家经验的比较。
Front Med (Lausanne). 2024 Mar 11;11:1345506. doi: 10.3389/fmed.2024.1345506. eCollection 2024.
2
The economic cost of dialysis: a comparison between peritoneal dialysis and in-center hemodialysis in a Spanish unit.透析的经济成本:西班牙一家医疗机构中腹膜透析与中心血液透析的比较
Adv Perit Dial. 1996;12:93-6.
3
Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.腹膜透析优先政策下终末期肾病患者一线透析方式的终身成本效益分析
BMC Nephrol. 2020 Feb 4;21(1):42. doi: 10.1186/s12882-020-1708-0.
4
Daily variation in death in patients treated by long-term dialysis: comparison of in-center hemodialysis to peritoneal and home hemodialysis.长期透析治疗患者的死亡日变化:中心血液透析与腹膜和家庭血液透析的比较。
Am J Kidney Dis. 2013 Jan;61(1):96-103. doi: 10.1053/j.ajkd.2012.07.008. Epub 2012 Aug 16.
5
Costs of Assisted Home Dialysis: A Single-Payer Canadian Model From Manitoba.家庭辅助透析的成本:来自加拿大曼尼托巴省的单一支付者模式
Kidney Med. 2021 Jul 7;3(6):942-950.e1. doi: 10.1016/j.xkme.2021.04.019. eCollection 2021 Nov-Dec.
6
Chronic Hemodialysis Therapy in the West.西方的慢性血液透析疗法。
Kidney Dis (Basel). 2015 Dec;1(3):178-86. doi: 10.1159/000441809. Epub 2015 Nov 18.
7
Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis.起始夜间家庭血液透析、医院血液透析和腹膜透析后第 1 年和第 2 年终末期肾病患者的直接和间接成本。
Nephrol Dial Transplant. 2019 Sep 1;34(9):1565-1576. doi: 10.1093/ndt/gfy395.
8
A cost evaluation of peritoneal dialysis and hemodialysis in the treatment of end-stage renal disease in Sao Paulo, Brazil.巴西圣保罗地区腹膜透析和血液透析治疗终末期肾病的成本评估。
Perit Dial Int. 2013 May-Jun;33(3):304-15. doi: 10.3747/pdi.2011.00138. Epub 2012 Dec 3.
9
Hidden Costs Associated with Conversion from Peritoneal Dialysis to Hemodialysis.与从腹膜透析转为血液透析相关的隐藏成本。
Kidney360. 2022 Mar 2;3(5):883-890. doi: 10.34067/KID.0007692021. eCollection 2022 May 26.
10
Cost Controversies of a "Home Dialysis First" Policy.“居家透析优先”政策的成本争议
Can J Kidney Health Dis. 2019 Aug 30;6:2054358119871541. doi: 10.1177/2054358119871541. eCollection 2019.

本文引用的文献

1
Economic Impact of Home Hemodialysis.家庭血液透析的经济影响。
Adv Chronic Kidney Dis. 2021 Mar;28(2):136-142. doi: 10.1053/j.ackd.2021.06.010.
2
Healthcare costs of patients on different renal replacement modalities - Analysis of Dutch health insurance claims data.不同肾脏替代治疗方式患者的医疗费用 - 荷兰健康保险索赔数据分析。
PLoS One. 2019 Aug 15;14(8):e0220800. doi: 10.1371/journal.pone.0220800. eCollection 2019.
3
Can economic incentives increase the use of home dialysis?经济激励能否增加家庭透析的使用?
Nephrol Dial Transplant. 2019 May 1;34(5):731-741. doi: 10.1093/ndt/gfy223.
4
US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States.《美国肾脏数据系统2016年年报:美国肾脏疾病流行病学》
Am J Kidney Dis. 2017 Mar;69(3 Suppl 1):A7-A8. doi: 10.1053/j.ajkd.2016.12.004.
5
Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.慢性肾脏病及肾脏替代治疗的医疗费用:瑞典一项基于人群的队列研究
BMJ Open. 2016 Oct 7;6(10):e012062. doi: 10.1136/bmjopen-2016-012062.
6
Cost-Effectiveness of High Dose Hemodialysis in Comparison to Conventional In-Center Hemodialysis in the Netherlands.荷兰高剂量血液透析与传统中心内血液透析的成本效益比较。
Adv Ther. 2016 Nov;33(11):2032-2048. doi: 10.1007/s12325-016-0408-4. Epub 2016 Sep 23.
7
The economic considerations of patients and caregivers in choice of dialysis modality.患者及照护者在选择透析方式时的经济考量
Hemodial Int. 2016 Oct;20(4):634-642. doi: 10.1111/hdi.12424. Epub 2016 May 15.
8
The financial impact of increasing home-based high dose haemodialysis and peritoneal dialysis.增加家庭高剂量血液透析和腹膜透析的财务影响。
BMC Nephrol. 2014 Oct 2;15:161. doi: 10.1186/1471-2369-15-161.
9
The cost-effectiveness of contemporary home haemodialysis modalities compared with facility haemodialysis: a systematic review of full economic evaluations.当代家庭血液透析模式与医疗机构血液透析的成本效益比较:全面经济评估的系统评价
Nephrology (Carlton). 2014 Aug;19(8):459-70. doi: 10.1111/nep.12269.
10
Reimbursement of dialysis: a comparison of seven countries.透析报销:七个国家的比较。
J Am Soc Nephrol. 2012 Aug;23(8):1291-8. doi: 10.1681/ASN.2011111094. Epub 2012 Jun 7.